Form 4: Edwards Lifesciences Director Leslie Stone Heisz Executes Stock Option and Sells Shares
SEC Form 4 Filing
Director Leslie Stone Heisz exercised stock options and sold shares of Edwards Lifesciences Corp on February 13, 2025.
Summary
- On February 13, 2025, Leslie Stone Heisz, a director of Edwards Lifesciences Corp, exercised stock options to acquire 5,739 shares of common stock at a price of $45.3167 per share.
- Simultaneously, Heisz sold 5,739 shares of common stock at a weighted average price of $75.8618, with prices ranging from $75.42 to $76.37.
- Following these transactions, Heisz directly owns 30,035 shares of Edwards Lifesciences Corp.
- The exercised stock option was originally granted on May 18, 2018, and was set to expire on May 17, 2025.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common for directors and officers of publicly traded companies. These transactions can be influenced by various factors, including personal financial planning and company performance.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in ownership by a company director.
Key Dates
| Date | Description |
|---|---|
| 05/18/2018 | Date Director Stock Option was granted |
| 05/17/2025 | Expiration date of Director Stock Option |
| 02/13/2025 | Date of transaction (exercise of stock option and sale of shares) |
Keywords
Form 4, Beneficial Ownership, Stock Option, Share Sale, Edwards Lifesciences, Director, Heisz
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.